Edotreotide trifluoroacetate

CAS : 204318-14-9

Ref. 3D-FE175690

Informations sur le produit

• Nom: Edotreotide trifluoroacetate
• Marque: Biosynth
• Description: Edotreotide trifluoroacetate is a diagnostic agent that is used to diagnose hepatic steatosis. It is a synthetic analog of somatostatin, which can be synthesized by the reaction of trifluoroacetic acid and hydroxyl compounds. Edotreotide trifluoroacetate is radiolabeled with technetium-99m and administered intravenously. The drug binds to receptors on the surface of proximal tubule cells in the liver, causing an uptake of this radionuclide in the area of interest. This diagnostic agent has also been shown to inhibit insulin release from pancreatic beta cells and improve glucose tolerance in patients with type 2 diabetes mellitus.

Propriétés chimiques

• Formule: C₆₅H₉₂N₁₄O₁₈S₂·xC₂HF₃O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder